首页> 美国卫生研究院文献>Cells >Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
【2h】

Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer

机译:了解胶质母细胞瘤生物标志物:用锤子敲山

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gliomas are the most frequent and deadly form of human primary brain tumors. Among them, the most common and aggressive type is the high-grade glioblastoma multiforme (GBM), which rapidly grows and renders patients a very poor prognosis. Meanwhile, cancer stem cells (CSCs) have been determined in gliomas and play vital roles in driving tumor growth due to their competency in self-renewal and proliferation. Studies of gliomas have recognized CSCs via specific markers. This review comprehensively examines the current knowledge of the most significant CSCs markers in gliomas in general and in glioblastoma in particular and specifically focuses on their outlook and importance in gliomas CSCs research. We suggest that CSCs should be the superior therapeutic approach by directly targeting the markers. In addition, we highlight the association of these markers with each other in relation to their cascading pathways, and interactions with functional miRNAs, providing the role of the networks axes in glioblastoma signaling pathways.
机译:神经胶质瘤是人类原发性脑肿瘤的最常见和最致命的形式。其中,最常见和侵略性的类型是多形性胶质母细胞瘤(GBM),它迅速生长,使患者的预后很差。同时,已经在神经胶质瘤中确定了癌症干细胞(CSC),并且由于它们具有自我更新和增殖的能力,它们在驱动肿瘤生长中起着至关重要的作用。对神经胶质瘤的研究已经通过特异性标记识别了CSC。这篇综述全面审查了一般意义上的神经胶质瘤,尤其是胶质母细胞瘤中最重要的CSCs标记物的当前知识,并特别着重于它们在神经胶质瘤CSCs研究中的前景和重要性。我们建议通过直接靶向标记物,CSCs应该是更好的治疗方法。此外,我们强调了这些标记物的级联途径以及与功能性miRNA的相互作用,从而提供了胶质母细胞瘤信号通路中网络轴的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号